APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Coagulation Factor VII

Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.

Selected research

Market Analysis & Forecast

Global Human Coagulation Factor VII Market Analysis and Forecast 2026-2032

26 December 2025198 pages

Choose your research edition.

Industry ResearchHuman Coagulation Factor VII Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Coagulation Factor VII Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Human Coagulation Factor VII Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Coagulation Factor VII Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Coagulation Factor VII Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.

Europe and North America are the largest region of Human Coagulation Factor VII, with about 40% market share respectively. NovoNordisk is the major manufacturer of industry.

This report presents an overview of global market for Human Coagulation Factor VII, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Human Coagulation Factor VII, also provides the sales of main regions and countries. Of the upcoming market potential for Human Coagulation Factor VII, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Coagulation Factor VII sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Coagulation Factor VII market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Coagulation Factor VII sales, projected growth trends, production technology, application and end-user industry.

Human Coagulation Factor VII Segment by Company

NovoNordisk

Human Coagulation Factor VII Segment by Type

Recombinant Factor VIII

Plasma-derived Factor VIII

Human Coagulation Factor VII Segment by Application

Hemophilia A

Spontanous / Trauma

Surgical

Others

Human Coagulation Factor VII Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor VII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor VII and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor VII.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Coagulation Factor VII in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Coagulation Factor VII manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Coagulation Factor VII sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Coagulation Factor VII Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Recombinant Factor VIII Major Manufacturers Table 3. Plasma-derived Factor VIII Major Manufacturers Table 4. Global Human Coagulation Factor VII Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hemophilia A Major Manufacturers Table 6. Spontanous / Trauma Major Manufacturers Table 7. Surgical Major Manufacturers Table 8. Others Major Manufacturers Table 9. Human Coagulation Factor VII Industry Trends Table 10. Human Coagulation Factor VII Industry Drivers Table 11. Human Coagulation Factor VII Industry Opportunities and Challenges Table 12. Human Coagulation Factor VII Industry Restraints Table 13. Global Human Coagulation Factor VII Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Human Coagulation Factor VII Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Human Coagulation Factor VII Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Human Coagulation Factor VII Revenue Market Share by Region (2021-2026) Table 17. Global Human Coagulation Factor VII Revenue Market Share by Region (2027-2032) Table 18. Global Human Coagulation Factor VII Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Mg) Table 19. Global Human Coagulation Factor VII Sales by Region (2021-2026) & (K Mg) Table 20. Global Human Coagulation Factor VII Sales by Region (2027-2032) & (K Mg) Table 21. Global Human Coagulation Factor VII Sales Market Share by Region (2021-2026) Table 22. Global Human Coagulation Factor VII Sales Market Share by Region (2027-2032) Table 23. Global Human Coagulation Factor VII Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Human Coagulation Factor VII Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Human Coagulation Factor VII Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Human Coagulation Factor VII Sales Market Share by Manufacturers (2021-2026) Table 27. Global Human Coagulation Factor VII Sales Price (USD/kg) of Manufacturers (2021-2026) Table 28. Global Human Coagulation Factor VII Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Human Coagulation Factor VII Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Human Coagulation Factor VII Manufacturers, Product Type & Application Table 31. Global Human Coagulation Factor VII Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Human Coagulation Factor VII by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Human Coagulation Factor VII Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Human Coagulation Factor VII Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Human Coagulation Factor VII Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Human Coagulation Factor VII Revenue Market Share by Type (2021-2026) Table 38. Global Human Coagulation Factor VII Revenue Market Share by Type (2027-2032) Table 39. Global Human Coagulation Factor VII Sales by Type 2021 VS 2025 VS 2032 (K Mg) Table 40. Global Human Coagulation Factor VII Sales by Type (2021-2026) & (K Mg) Table 41. Global Human Coagulation Factor VII Sales by Type (2027-2032) & (K Mg) Table 42. Global Human Coagulation Factor VII Sales Market Share by Type (2021-2026) Table 43. Global Human Coagulation Factor VII Sales Market Share by Type (2027-2032) Table 44. Global Human Coagulation Factor VII Price by Type (2021-2026) & (USD/kg) Table 45. Global Human Coagulation Factor VII Price by Type (2027-2032) & (USD/kg) Table 46. Global Human Coagulation Factor VII Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Human Coagulation Factor VII Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Human Coagulation Factor VII Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Human Coagulation Factor VII Revenue Market Share by Application (2021-2026) Table 50. Global Human Coagulation Factor VII Revenue Market Share by Application (2027-2032) Table 51. Global Human Coagulation Factor VII Sales by Application 2021 VS 2025 VS 2032 (K Mg) Table 52. Global Human Coagulation Factor VII Sales by Application (2021-2026) & (K Mg) Table 53. Global Human Coagulation Factor VII Sales by Application (2027-2032) & (K Mg) Table 54. Global Human Coagulation Factor VII Sales Market Share by Application (2021-2026) Table 55. Global Human Coagulation Factor VII Sales Market Share by Application (2027-2032) Table 56. Global Human Coagulation Factor VII Price by Application (2021-2026) & (USD/kg) Table 57. Global Human Coagulation Factor VII Price by Application (2027-2032) & (USD/kg) Table 58. NovoNordisk Company Information Table 59. NovoNordisk Business Overview Table 60. NovoNordisk Human Coagulation Factor VII Sales (K Mg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 61. NovoNordisk Human Coagulation Factor VII Product Portfolio Table 62. NovoNordisk Recent Development Table 63. North America Human Coagulation Factor VII Revenue by Type (2021-2026) & (US$ Million) Table 64. North America Human Coagulation Factor VII Revenue by Type (2027-2032) & (US$ Million) Table 65. North America Human Coagulation Factor VII Sales by Type (2021-2026) & (K Mg) Table 66. North America Human Coagulation Factor VII Sales by Type (2027-2032) & (K Mg) Table 67. North America Human Coagulation Factor VII Sales Price by Type (2021-2026) & (USD/kg) Table 68. North America Human Coagulation Factor VII Sales Price by Type (2027-2032) & (USD/kg) Table 69. North America Human Coagulation Factor VII Revenue by Application (2021-2026) & (US$ Million) Table 70. North America Human Coagulation Factor VII Revenue by Application (2027-2032) & (US$ Million) Table 71. North America Human Coagulation Factor VII Sales by Application (2021-2026) & (K Mg) Table 72. North America Human Coagulation Factor VII Sales by Application (2027-2032) & (K Mg) Table 73. North America Human Coagulation Factor VII Sales Price by Application (2021-2026) & (USD/kg) Table 74. North America Human Coagulation Factor VII Sales Price by Application (2027-2032) & (USD/kg) Table 75. North America Human Coagulation Factor VII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. North America Human Coagulation Factor VII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 77. North America Human Coagulation Factor VII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 78. North America Human Coagulation Factor VII Sales by Country (2021 VS 2025 VS 2032) & (K Mg) Table 79. North America Human Coagulation Factor VII Sales by Country (2021-2026) & (K Mg) Table 80. North America Human Coagulation Factor VII Sales by Country (2027-2032) & (K Mg) Table 81. North America Human Coagulation Factor VII Sales Price by Country (2021-2026) & (USD/kg) Table 82. North America Human Coagulation Factor VII Sales Price by Country (2027-2032) & (USD/kg) Table 83. United States Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 84. Canada Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 85. Mexico Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 86. Europe Human Coagulation Factor VII Revenue by Type (2021-2026) & (US$ Million) Table 87. Europe Human Coagulation Factor VII Revenue by Type (2027-2032) & (US$ Million) Table 88. Europe Human Coagulation Factor VII Sales by Type (2021-2026) & (K Mg) Table 89. Europe Human Coagulation Factor VII Sales by Type (2027-2032) & (K Mg) Table 90. Europe Human Coagulation Factor VII Sales Price by Type (2021-2026) & (USD/kg) Table 91. Europe Human Coagulation Factor VII Sales Price by Type (2027-2032) & (USD/kg) Table 92. Europe Human Coagulation Factor VII Revenue by Application (2021-2026) & (US$ Million) Table 93. Europe Human Coagulation Factor VII Revenue by Application (2027-2032) & (US$ Million) Table 94. Europe Human Coagulation Factor VII Sales by Application (2021-2026) & (K Mg) Table 95. Europe Human Coagulation Factor VII Sales by Application (2027-2032) & (K Mg) Table 96. Europe Human Coagulation Factor VII Sales Price by Application (2021-2026) & (USD/kg) Table 97. Europe Human Coagulation Factor VII Sales Price by Application (2027-2032) & (USD/kg) Table 98. Europe Human Coagulation Factor VII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Human Coagulation Factor VII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. Europe Human Coagulation Factor VII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. Europe Human Coagulation Factor VII Sales by Country (2021 VS 2025 VS 2032) & (K Mg) Table 102. Europe Human Coagulation Factor VII Sales by Country (2021-2026) & (K Mg) Table 103. Europe Human Coagulation Factor VII Sales by Country (2027-2032) & (K Mg) Table 104. Europe Human Coagulation Factor VII Sales Price by Country (2021-2026) & (USD/kg) Table 105. Europe Human Coagulation Factor VII Sales Price by Country (2027-2032) & (USD/kg) Table 106. Germany Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 107. France Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 108. U.K. Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 109. Italy Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 110. Russia Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 111. Spain Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 112. Netherlands Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 113. Switzerland Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 114. Sweden Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 115. Poland Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 116. China Human Coagulation Factor VII Revenue by Type (2021-2026) & (US$ Million) Table 117. China Human Coagulation Factor VII Revenue by Type (2027-2032) & (US$ Million) Table 118. China Human Coagulation Factor VII Sales by Type (2021-2026) & (K Mg) Table 119. China Human Coagulation Factor VII Sales by Type (2027-2032) & (K Mg) Table 120. China Human Coagulation Factor VII Sales Price by Type (2021-2026) & (USD/kg) Table 121. China Human Coagulation Factor VII Sales Price by Type (2027-2032) & (USD/kg) Table 122. China Human Coagulation Factor VII Revenue by Application (2021-2026) & (US$ Million) Table 123. China Human Coagulation Factor VII Revenue by Application (2027-2032) & (US$ Million) Table 124. China Human Coagulation Factor VII Sales by Application (2021-2026) & (K Mg) Table 125. China Human Coagulation Factor VII Sales by Application (2027-2032) & (K Mg) Table 126. China Human Coagulation Factor VII Sales Price by Application (2021-2026) & (USD/kg) Table 127. China Human Coagulation Factor VII Sales Price by Application (2027-2032) & (USD/kg) Table 128. Asia Human Coagulation Factor VII Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia Human Coagulation Factor VII Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia Human Coagulation Factor VII Sales by Type (2021-2026) & (K Mg) Table 131. Asia Human Coagulation Factor VII Sales by Type (2027-2032) & (K Mg) Table 132. Asia Human Coagulation Factor VII Sales Price by Type (2021-2026) & (USD/kg) Table 133. Asia Human Coagulation Factor VII Sales Price by Type (2027-2032) & (USD/kg) Table 134. Asia Human Coagulation Factor VII Revenue by Application (2021-2026) & (US$ Million) Table 135. Asia Human Coagulation Factor VII Revenue by Application (2027-2032) & (US$ Million) Table 136. Asia Human Coagulation Factor VII Sales by Application (2021-2026) & (K Mg) Table 137. Asia Human Coagulation Factor VII Sales by Application (2027-2032) & (K Mg) Table 138. Asia Human Coagulation Factor VII Sales Price by Application (2021-2026) & (USD/kg) Table 139. Asia Human Coagulation Factor VII Sales Price by Application (2027-2032) & (USD/kg) Table 140. Asia Human Coagulation Factor VII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Asia Human Coagulation Factor VII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. Asia Human Coagulation Factor VII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. Asia Human Coagulation Factor VII Sales by Country (2021 VS 2025 VS 2032) & (K Mg) Table 144. Asia Human Coagulation Factor VII Sales by Country (2021-2026) & (K Mg) Table 145. Asia Human Coagulation Factor VII Sales by Country (2027-2032) & (K Mg) Table 146. Asia Human Coagulation Factor VII Sales Price by Country (2021-2026) & (USD/kg) Table 147. Asia Human Coagulation Factor VII Sales Price by Country (2027-2032) & (USD/kg) Table 148. Japan Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 149. South Korea Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 150. India Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 151. Australia Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 152. Taiwan Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 153. Southeast Asia Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 154. SAMEA Human Coagulation Factor VII Revenue by Type (2021-2026) & (US$ Million) Table 155. SAMEA Human Coagulation Factor VII Revenue by Type (2027-2032) & (US$ Million) Table 156. SAMEA Human Coagulation Factor VII Sales by Type (2021-2026) & (K Mg) Table 157. SAMEA Human Coagulation Factor VII Sales by Type (2027-2032) & (K Mg) Table 158. SAMEA Human Coagulation Factor VII Sales Price by Type (2021-2026) & (USD/kg) Table 159. SAMEA Human Coagulation Factor VII Sales Price by Type (2027-2032) & (USD/kg) Table 160. SAMEA Human Coagulation Factor VII Revenue by Application (2021-2026) & (US$ Million) Table 161. SAMEA Human Coagulation Factor VII Revenue by Application (2027-2032) & (US$ Million) Table 162. SAMEA Human Coagulation Factor VII Sales by Application (2021-2026) & (K Mg) Table 163. SAMEA Human Coagulation Factor VII Sales by Application (2027-2032) & (K Mg) Table 164. SAMEA Human Coagulation Factor VII Sales Price by Application (2021-2026) & (USD/kg) Table 165. SAMEA Human Coagulation Factor VII Sales Price by Application (2027-2032) & (USD/kg) Table 166. SAMEA Human Coagulation Factor VII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. SAMEA Human Coagulation Factor VII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. SAMEA Human Coagulation Factor VII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. SAMEA Human Coagulation Factor VII Sales by Country (2021 VS 2025 VS 2032) & (K Mg) Table 170. SAMEA Human Coagulation Factor VII Sales by Country (2021-2026) & (K Mg) Table 171. SAMEA Human Coagulation Factor VII Sales by Country (2027-2032) & (K Mg) Table 172. SAMEA Human Coagulation Factor VII Sales Price by Country (2021-2026) & (USD/kg) Table 173. SAMEA Human Coagulation Factor VII Sales Price by Country (2027-2032) & (USD/kg) Table 174. Brazil Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 175. Argentina Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 176. Chile Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 177. Colombia Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 178. Peru Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 179. Saudi Arabia Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 180. Israel Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 181. UAE Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 182. Turkey Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 183. Iran Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 184. Egypt Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Table 185. Key Raw Materials Table 186. Raw Materials Key Suppliers Table 187. Human Coagulation Factor VII Distributors List Table 188. Human Coagulation Factor VII Customers List Table 189. Research Programs/Design for This Report Table 190. Authors List of This Report Table 191. Secondary Sources Table 192. Primary Sources List of Figures Figure 1. Human Coagulation Factor VII Image Figure 2. Global Human Coagulation Factor VII Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Coagulation Factor VII Market Size Share 2021 VS 2025 VS 2032 Figure 4. Recombinant Factor VIII Image Figure 5. Plasma-derived Factor VIII Image Figure 6. Global Human Coagulation Factor VII Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Human Coagulation Factor VII Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hemophilia A Image Figure 9. Spontanous / Trauma Image Figure 10. Surgical Image Figure 11. Others Image Figure 12. Global Human Coagulation Factor VII Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Human Coagulation Factor VII Revenue (2021-2032) & (US$ Million) Figure 14. Global Human Coagulation Factor VII Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Human Coagulation Factor VII Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Human Coagulation Factor VII Revenue Market Share by Region (2021-2032) Figure 17. Global Human Coagulation Factor VII Sales (2021-2032) & (K Mg) Figure 18. Global Human Coagulation Factor VII Sales by Region: 2021 VS 2025 VS 2032 (K Mg) Figure 19. Global Human Coagulation Factor VII Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Human Coagulation Factor VII Sales YoY (2021-2032) & (K Mg) Figure 21. Europe Human Coagulation Factor VII Sales YoY (2021-2032) & (K Mg) Figure 22. China Human Coagulation Factor VII Sales YoY (2021-2032) & (K Mg) Figure 23. Asia (Excluding China) Human Coagulation Factor VII Sales YoY (2021-2032) & (K Mg) Figure 24. South America, Middle East and Africa Human Coagulation Factor VII Sales YoY (2021-2032) & (K Mg) Figure 25. Global Human Coagulation Factor VII Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Human Coagulation Factor VII Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Human Coagulation Factor VII Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Human Coagulation Factor VII Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Human Coagulation Factor VII Revenue Market Share by Type (2021-2032) Figure 31. Global Human Coagulation Factor VII Sales by Type (2021 VS 2025 VS 2032) & (K Mg) Figure 32. Global Human Coagulation Factor VII Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Human Coagulation Factor VII Sales Market Share by Type (2021-2032) Figure 34. Global Human Coagulation Factor VII Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Human Coagulation Factor VII Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Human Coagulation Factor VII Revenue Market Share by Application (2021-2032) Figure 37. Global Human Coagulation Factor VII Sales by Application (2021 VS 2025 VS 2032) & (K Mg) Figure 38. Global Human Coagulation Factor VII Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Human Coagulation Factor VII Sales Market Share by Application (2021-2032) Figure 40. North America Human Coagulation Factor VII Revenue Share by Type (2021-2032) Figure 41. North America Human Coagulation Factor VII Sales Share by Type (2021-2032) Figure 42. North America Human Coagulation Factor VII Revenue Share by Application (2021-2032) Figure 43. North America Human Coagulation Factor VII Sales Share by Application (2021-2032) Figure 44. North America Human Coagulation Factor VII Revenue Share by Country (2021-2032) Figure 45. North America Human Coagulation Factor VII Sales Share by Country (2021-2032) Figure 46. Europe Human Coagulation Factor VII Revenue Share by Type (2021-2032) Figure 47. Europe Human Coagulation Factor VII Sales Share by Type (2021-2032) Figure 48. Europe Human Coagulation Factor VII Revenue Share by Application (2021-2032) Figure 49. Europe Human Coagulation Factor VII Sales Share by Application (2021-2032) Figure 50. Europe Human Coagulation Factor VII Revenue Share by Country (2021-2032) Figure 51. Europe Human Coagulation Factor VII Sales Share by Country (2021-2032) Figure 52. China Human Coagulation Factor VII Revenue Share by Type (2021-2032) Figure 53. China Human Coagulation Factor VII Sales Share by Type (2021-2032) Figure 54. China Human Coagulation Factor VII Revenue Share by Application (2021-2032) Figure 55. China Human Coagulation Factor VII Sales Share by Application (2021-2032) Figure 56. Asia Human Coagulation Factor VII Revenue Share by Type (2021-2032) Figure 57. Asia Human Coagulation Factor VII Sales Share by Type (2021-2032) Figure 58. Asia Human Coagulation Factor VII Revenue Share by Application (2021-2032) Figure 59. Asia Human Coagulation Factor VII Sales Share by Application (2021-2032) Figure 60. Asia Human Coagulation Factor VII Revenue Share by Country (2021-2032) Figure 61. Asia Human Coagulation Factor VII Sales Share by Country (2021-2032) Figure 62. SAMEA Human Coagulation Factor VII Revenue Share by Type (2021-2032) Figure 63. SAMEA Human Coagulation Factor VII Sales Share by Type (2021-2032) Figure 64. SAMEA Human Coagulation Factor VII Revenue Share by Application (2021-2032) Figure 65. SAMEA Human Coagulation Factor VII Sales Share by Application (2021-2032) Figure 66. SAMEA Human Coagulation Factor VII Revenue Share by Country (2021-2032) Figure 67. SAMEA Human Coagulation Factor VII Sales Share by Country (2021-2032) Figure 68. Human Coagulation Factor VII Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Human Coagulation Factor VII Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Factor VIII
  • Plasma-derived Factor VIII
Applications
  • Hemophilia A
  • Spontanous / Trauma
  • Surgical
  • Others
Companies covered
  • NovoNordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Coagulation Factor VII Market by Type
  3. 1.2.1 Global Human Coagulation Factor VII Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Recombinant Factor VIII
  5. 1.2.3 Plasma-derived Factor VIII
  6. 1.3 Human Coagulation Factor VII Market by Application
  7. 1.3.1 Global Human Coagulation Factor VII Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hemophilia A
  9. 1.3.3 Spontanous / Trauma
  10. 1.3.4 Surgical
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Human Coagulation Factor VII Market Dynamics
  1. 2.1 Human Coagulation Factor VII Industry Trends
  2. 2.2 Human Coagulation Factor VII Industry Drivers
  3. 2.3 Human Coagulation Factor VII Industry Opportunities and Challenges
  4. 2.4 Human Coagulation Factor VII Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Coagulation Factor VII Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Coagulation Factor VII Revenue by Region
  3. 3.2.1 Global Human Coagulation Factor VII Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Coagulation Factor VII Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Coagulation Factor VII Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Coagulation Factor VII Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Coagulation Factor VII Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Coagulation Factor VII Sales by Region
  9. 3.4.1 Global Human Coagulation Factor VII Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Coagulation Factor VII Sales by Region (2021-2026)
  11. 3.4.3 Global Human Coagulation Factor VII Sales by Region (2027-2032)
  12. 3.4.4 Global Human Coagulation Factor VII Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Coagulation Factor VII Revenue by Manufacturers
  2. 4.1.1 Global Human Coagulation Factor VII Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Coagulation Factor VII Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Coagulation Factor VII Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Coagulation Factor VII Sales by Manufacturers
  6. 4.2.1 Global Human Coagulation Factor VII Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Coagulation Factor VII Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Coagulation Factor VII Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Coagulation Factor VII Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Coagulation Factor VII Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Coagulation Factor VII Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Coagulation Factor VII Manufacturers, Product Type & Application
  13. 4.7 Global Human Coagulation Factor VII Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Coagulation Factor VII Market CR5 and HHI
  16. 4.8.2 2025 Human Coagulation Factor VII Tier 1, Tier 2, and Tier 3
5 Human Coagulation Factor VII Market by Type
  1. 5.1 Global Human Coagulation Factor VII Revenue by Type
  2. 5.1.1 Global Human Coagulation Factor VII Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Coagulation Factor VII Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Coagulation Factor VII Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Coagulation Factor VII Sales by Type
  6. 5.2.1 Global Human Coagulation Factor VII Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Coagulation Factor VII Sales by Type (2021-2032) & (K Mg)
  8. 5.2.3 Global Human Coagulation Factor VII Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Coagulation Factor VII Price by Type
6 Human Coagulation Factor VII Market by Application
  1. 6.1 Global Human Coagulation Factor VII Revenue by Application
  2. 6.1.1 Global Human Coagulation Factor VII Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Coagulation Factor VII Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Coagulation Factor VII Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Coagulation Factor VII Sales by Application
  6. 6.2.1 Global Human Coagulation Factor VII Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Coagulation Factor VII Sales by Application (2021-2032) & (K Mg)
  8. 6.2.3 Global Human Coagulation Factor VII Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Coagulation Factor VII Price by Application
7 Company Profiles
  1. 7.1 NovoNordisk
  2. 7.1.1 NovoNordisk Company Information
  3. 7.1.2 NovoNordisk Business Overview
  4. 7.1.3 NovoNordisk Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 NovoNordisk Human Coagulation Factor VII Product Portfolio
  6. 7.1.5 NovoNordisk Recent Developments
8 North America
  1. 8.1 North America Human Coagulation Factor VII Market Size by Type
  2. 8.1.1 North America Human Coagulation Factor VII Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Coagulation Factor VII Sales by Type (2021-2032)
  4. 8.1.3 North America Human Coagulation Factor VII Price by Type (2021-2032)
  5. 8.2 North America Human Coagulation Factor VII Market Size by Application
  6. 8.2.1 North America Human Coagulation Factor VII Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Coagulation Factor VII Sales by Application (2021-2032)
  8. 8.2.3 North America Human Coagulation Factor VII Price by Application (2021-2032)
  9. 8.3 North America Human Coagulation Factor VII Market Size by Country
  10. 8.3.1 North America Human Coagulation Factor VII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Coagulation Factor VII Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Coagulation Factor VII Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Human Coagulation Factor VII Market Size by Type
  2. 9.1.1 Europe Human Coagulation Factor VII Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Coagulation Factor VII Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Coagulation Factor VII Price by Type (2021-2032)
  5. 9.2 Europe Human Coagulation Factor VII Market Size by Application
  6. 9.2.1 Europe Human Coagulation Factor VII Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Coagulation Factor VII Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Coagulation Factor VII Price by Application (2021-2032)
  9. 9.3 Europe Human Coagulation Factor VII Market Size by Country
  10. 9.3.1 Europe Human Coagulation Factor VII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Coagulation Factor VII Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Coagulation Factor VII Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Human Coagulation Factor VII Market Size by Type
  2. 10.1.1 China Human Coagulation Factor VII Revenue by Type (2021-2032)
  3. 10.1.2 China Human Coagulation Factor VII Sales by Type (2021-2032)
  4. 10.1.3 China Human Coagulation Factor VII Price by Type (2021-2032)
  5. 10.2 China Human Coagulation Factor VII Market Size by Application
  6. 10.2.1 China Human Coagulation Factor VII Revenue by Application (2021-2032)
  7. 10.2.2 China Human Coagulation Factor VII Sales by Application (2021-2032)
  8. 10.2.3 China Human Coagulation Factor VII Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Coagulation Factor VII Market Size by Type
  2. 11.1.1 Asia Human Coagulation Factor VII Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Coagulation Factor VII Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Coagulation Factor VII Price by Type (2021-2032)
  5. 11.2 Asia Human Coagulation Factor VII Market Size by Application
  6. 11.2.1 Asia Human Coagulation Factor VII Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Coagulation Factor VII Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Coagulation Factor VII Price by Application (2021-2032)
  9. 11.3 Asia Human Coagulation Factor VII Market Size by Country
  10. 11.3.1 Asia Human Coagulation Factor VII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Coagulation Factor VII Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Coagulation Factor VII Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Coagulation Factor VII Market Size by Type
  2. 12.1.1 SAMEA Human Coagulation Factor VII Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Coagulation Factor VII Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Coagulation Factor VII Price by Type (2021-2032)
  5. 12.2 SAMEA Human Coagulation Factor VII Market Size by Application
  6. 12.2.1 SAMEA Human Coagulation Factor VII Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Coagulation Factor VII Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Coagulation Factor VII Price by Application (2021-2032)
  9. 12.3 SAMEA Human Coagulation Factor VII Market Size by Country
  10. 12.3.1 SAMEA Human Coagulation Factor VII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Coagulation Factor VII Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Coagulation Factor VII Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Coagulation Factor VII Value Chain Analysis
  2. 13.1.1 Human Coagulation Factor VII Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Coagulation Factor VII Production Mode & Process
  6. 13.2 Human Coagulation Factor VII Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Coagulation Factor VII Distributors
  9. 13.2.3 Human Coagulation Factor VII Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst